Recent studies show that elderly patients taking Avandia, or also known as rosiglitazone, have a 15% higher death rate than those taking a similar drug Actos, also known as pioglitazone.  Specifically, the drug appears to increase the risk of heart attacks, strokes or other cardiovascular events.  While additional research is suggested by the medical community, this is an important relationship that residents of nursing facilities and their families should keep in mind.  Those taking either of the drugs should consider talking with their treating physicians about the risks and benefits of these therapies, and whether other therapies should be considered as an alternative.  For more information click HERE for the full New York Times article.